글로벌 페닐케톤뇨증(PKU) 치료 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력 글로벌 페닐케톤뇨증(PKU) 치료 시장

페닐케톤뇨증(PKU) 치료 시장 규모는 2022년부터 2029년까지의 예측 기간 동안 연평균 10.95%의 성장률을 기록할 것으로 예상됩니다. Data Bridge Market Research의 페닐케톤뇨증(PKU) 치료 시장 보고서는 예측 기간 동안 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다.

페닐케톤뇨증(PKU)은 기본적으로 혈액 내 페닐알라닌(아미노산) 수치를 증가시키는 희귀 유전성 질환입니다. 페닐알라닌은 음식과 식단에서 얻은 단백질로 구성된 아미노산입니다. 페닐알라닌 하이드록실화 효소는 인체에서 페닐알라닌을 티로신 아미노산으로 전환합니다. 혈액 내 페닐알라닌이 너무 많으면 정신 장애, 발작 및 기타 많은 치료되지 않은 장애가 발생할 수 있습니다.

게놈학 및 생물정보학 분야의 연구 증가와 전 세계 사람들의 인식 증가는 2022년에서 2029년의 예측 기간 동안 시장 성장을 가속화할 것으로 예상됩니다. 또한, 게놈학 및 생물정보학 분야의 연구 증가와 신약 개발 및 상용화 증가는 시장 성장의 길을 더욱 개척할 것입니다. 생산 기술의 기술적 진보와 현대화 증가, 신흥 경제권의 수요 증가도 위에 언급된 예측 기간 동안 시장의 전반적인 성장을 촉진할 것으로 예상됩니다. 그러나 치료의 전반적인 높은 비용의 증가는 시장 성장률을 제한할 것으로 예상됩니다. 반면에 엄격한 정부 규제도 시장의 전반적인 성장을 방해합니다.

 In addition, the rise in the research and development activities in the market coupled with surge in the advancements in the health care industry are likely to create various new opportunities that will impact this phenylketonuria (PKU) treatment market growth in the forecast period of 2022 to 2029.The factors such as unfavorable reimbursement and rise in the lack of awareness among the patient and physician about phenylketonuria are estimated to challenge the market’s growth.

This phenylketonuria (PKU) treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the phenylketonuria (PKU) treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Phenylketonuria (PKU) Treatment Market Scope and Market Size

Phenylketonuria (PKU) treatment market is segmented on the basis of type, drugs type, therapy type, route of administration and end-user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the phenylketonuria (PKU) treatment market is segmented into hyperphenylalaninemia, mild PKU and moderate or variant and classic PKU.
• Based on drugs type, the phenylketonuria (PKU) treatment market is segmented into kuvan, sapropterin, palynziq, pagvaliase and biopten.
• Based on therapy type, the phenylketonuria (PKU) treatment market is segmented into gene therapy and dietary therapy.
• Based on route of administration, the phenylketonuria (PKU) treatment market is segmented into oral, intravenous, subcutaneous and others.
• The phenylketonuria (PKU) treatment market is also segmented on the basis of end-user into hospitals, homecare, specialty clinics and others.

Phenylketonuria (PKU) Treatment Market Country Level Analysis

Phenylketonuria (PKU) treatment market is analyzed and market size information is provided by type, drugs type, therapy type, route of administration and end-user as referenced above.

The countries covered in the phenylketonuria (PKU) treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America leads the phenylketonuria (PKU) treatment market due to the rise in the favorable regulations, rising government initiatives for the treatment of PKU and continuous research and development and commercialization of novel drugs in this region. Europe region, on the other hand is projected to expand at a significant growth rate because of the rise in the awareness amongst the people and increase in the research in the field of genomics and bioinformatics in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Phenylketonuria (PKU) treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Phenylketonuria (PKU) Treatment Market Share Analysis

Phenylketonuria (PKU) treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to phenylketonuria (PKU) treatment market.

페닐케톤뇨증(PKU) 치료 시장 보고서에서 활동하는 주요 기업으로는 DAIICHI SANKYO COMPANY, Ajinomoto Cambrooke, Inc., Applied Biomedical, LLC, MTW Endoskopie Manufaktur, American Gene Technologies., Ultragenyx Pharmaceutical, Nutricia, Reckitt Benckiser Group plc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Solvay, Abbott, Promin, SOM BIOTECH, Synthetic Biologics, Inc., Nestlé India Ltd., Codexis, BioMarin, Erytech Pharma 등이 있습니다.

SKU-42466